Simtra BioPharma Solutions

Simtra BioPharma Solutions is an independently owned contract development and manufacturing organization (CDMO) with over 65 years of experience in sterile injectable drug products. The company operates manufacturing facilities in Bloomington, Indiana, and Halle/Westfalen, Germany, providing high-quality, cGMP-compliant sterile fill/finish services to pharmaceutical and biotech companies worldwide. Their core services include formulation development, lyophilization cycle optimization, technology transfer, analytical testing, and specialized containment for potent compounds. Simtra's manufacturing capabilities encompass a variety of sterile injectable delivery systems, such as prefilled syringes, liquid and lyophilized vials, and diluents for reconstitution. They support a wide range of product types, including biologics, cytotoxics, antibody drug conjugates, small molecules, and vaccines. With a commitment to precision and quality, Simtra partners with clients to address formulation challenges and ensure timely delivery of products to over 120 countries.

Pharmaceuticals Parsippany-Troy Hills, United States ~423 employees

Work at Simtra BioPharma Solutions in HR or recruiting? Claim this page

Employees
423
+3.2% in the 3 months to Jun 2025
Revenue / employee
$1.4M
Revenue ~$574M
Total funding
$500K
Last round Dec 2024
12-month attrition
6.5%
Tech: 12%
H1B sponsor
NA
Open jobs
42
Last 30 days

Simtra BioPharma Solutions FAQ

How many employees does Simtra BioPharma Solutions have?

Simtra BioPharma Solutions has about 423 employees, up 3.2% over the 3 months to Jun 2025.

What is Simtra BioPharma Solutions's revenue per employee?

Simtra BioPharma Solutions makes about $1.36M in revenue per employee, based on $573.9M annual revenue and 423 employees.

How much funding has Simtra BioPharma Solutions raised?

Simtra BioPharma Solutions has raised $500K in total funding.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.